← Leaderboards
Jordan J Tang
Oklahoma Medical Research Foundation
$8,081,921
Attributed
$8,081,921
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $951.2K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,081,921 · 4
By mechanism
R01$5,895,009 · 2
U19$2,179,734 · 1
P41$7,178 · 1
Top collaborators
No co-investigators on record.
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- Kenneth Mark Coggeshall$14,637,824
- A. Darise Farris$16,682,449
- Judith A James$55,525,870
- Linda F. Thompson$14,550,182
- Shinichiro Kurosawa$10,924,747
Others in their field
Top investigators on “Endopeptidases”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,747,687
- Daniel J Finley · Harvard University (Medical School)$15,973,634
- Steven M Finkbeiner · J. David Gladstone Institutes$15,772,951
- Mark Hochstrasser · University Of Chicago$15,184,757
- Ron R Kopito · Stanford University$14,745,061
- Peipei Ping · University Of California Los Angeles$14,589,966
Research focus
EndopeptidasesX Ray CrystallographyProtease InhibitorProteinsStructureInhibitor/AntagonistPeptide HydrolasesEnzyme ComplexBinding (Molecular Function)Toxic EffectPropertySmall MoleculeDesignLaboratory MouseCellsBlood - Brain Barrier AnatomyCathepsinsDrug Design /Synthesis /ProductionCleaved CellAlzheimer&AposBlood Brain BarrierDrug Screening /EvaluationBeta-Site App Cleaving Enzyme 1Amyloid Beta-Protein Precursor
Grant awards (20)
Beta Secretase Inhibition for Treating Alzheimer's Disease$206,330
R01 · FY2011 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$495,902
R01 · FY2010 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$479,615
R01 · FY2009 · AG · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$466,591
R01 · FY2008 · AG · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$453,046
U19 · FY2008 · AI · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$456,011
R01 · FY2007 · AG · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$306,928
U19 · FY2007 · AI · contact PI
Therapeutic Interventions Targeted on Anthrax Toxins$470,912
U19 · FY2006 · AI · contact PI
Beta Secretase Inhibition for Treating Alzheimer's Disease$470,461
R01 · FY2006 · AG · contact PI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$480,268
R01 · FY2005 · AG
Therapeutic Interventions Targeted on Anthrax Toxins$470,894
U19 · FY2005 · AI
Therapeutic Interventions Targeted on Anthrax Toxins$477,954
U19 · FY2004 · AI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$468,407
R01 · FY2004 · AG
CRYSTAL STRUCTURE OF BETA-SECRETASEBOUND TO INHIBITORS$7,178
P41 · FY2004 · RR
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$454,992
R01 · FY2003 · AG
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$441,740
R01 · FY2002 · AG
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$356,991
R01 · FY2002 · AI
SECRETASE INHIBITORS FOR TREATING ALZHEIMER'S DISEASE$434,612
R01 · FY2001 · AG
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$346,592
R01 · FY2001 · AI
MUTATIONS EFFECTS ON INHIBITION OF HIV PROTEASE$336,497
R01 · FY2000 · AI